Crossref
0949 Development and validation of a selective melanocortin 1 receptor antibody agonist
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S164
DOI: 10.1016/j.jid.2026.06.980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von J.S. Smith und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Smith, J., Orofino, J., Wren, E., Meara, E., Kupper, T., & Kruse, A. (2026). 0949 Development and validation of a selective melanocortin 1 receptor antibody agonist. Journal of Investigative Dermatology, 146(8), S164. https://doi.org/10.1016/j.jid.2026.06.980
Vancouver
Smith J, Orofino J, Wren E, Meara E, Kupper T, Kruse A. 0949 Development and validation of a selective melanocortin 1 receptor antibody agonist. Journal of Investigative Dermatology. 2026;146(8):S164. doi:10.1016/j.jid.2026.06.980
BibTeX
@article{Smith2026,
author = {Smith, J.S. and Orofino, J. and Wren, E. and Meara, E. and Kupper, T. and Kruse, A.},
title = {0949 Development and validation of a selective melanocortin 1 receptor antibody agonist},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S164},
doi = {10.1016/j.jid.2026.06.980}
}
EUVIMED